Dudediligence.

Humacyte, Inc

HUMANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$517,000Mar ’25$301,000Jun ’25$753,000Sep ’25$467,000Dec ’25$495,000Mar ’26$406,000Jun ’26
Net income, by quarter
−$39.2MSep ’24−$20.9MDec ’24$39.1MMar ’25−$37.7MJun ’25−$17.5MSep ’25−$24.8MDec ’25−$17.6MMar ’26−$36.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$0.00$2.0M
Gross profitnone on filenone on filenone on file$0.00−$7.7M
Operating income−$81.2M−$84.6M−$100.0M−$114.4M−$108.1M
Net income−$26.5M−$12.0M−$110.8M−$148.7M−$40.8M
Operating cash flow−$81.2M−$71.1M−$73.3M−$98.1M−$105.0M
Free cash flow−$81.4M−$72.2M−$75.6M−$99.7M−$105.9M
Cash$217.5M$149.8M$80.4M$44.9M$50.5M
Debt$30.0Mnone on filenone on file$0.00$35.4M
Shares outstanding103.0M103.2M103.7M130.0M193.0M